MOG and myeloid sarcoma: The results of our study are consistent with the findings of these previous studies, given that we found similar levels of soluble anti-MOG and anti-MBP antibodies in the blood of patients with MS and healthy controls, which does not allow us to assign a diagnostic value to these soluble circulating autoantibodies.